Summary & Overview
HCPCS Q4241: Polycyte Topical, per 0.5 cc
HCPCS Level II code Q4241 represents Polycyte, a topical preparation supplied per 0.5 cc. The code is used to report dispensing or administration of this topical pharmaceutical in outpatient and ambulatory care settings, including dermatology and wound care clinics. Nationally, use of a specific HCPCS Level II code for a topical agent like Polycyte matters for standardized reporting, billing transparency, and tracking utilization of specialty topical products.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical context, typical sites of service, and the payers commonly involved in coverage decisions. The publication also summarizes available benchmarks where provided, notes relevant billing considerations, and highlights any recent policy updates affecting HCPCS Level II product codes.
This resource is written for a national audience and aims to help billing professionals, clinicians, and policy analysts quickly understand what HCPCS Level II code Q4241 denotes, where it is commonly used, and which major payers are relevant to coverage and claims processing. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q4241 describes Polycyte, for topical use only, per 0.5 cc. The service type is a topical pharmaceutical product, intended for direct application to the skin or mucosal surface. The typical site of service is outpatient clinic or ambulatory care settings where topical agents are applied, including dermatology clinics, wound care centers, and other ambulatory care environments.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a chronic or acute dermatologic wound or ulcer requiring a topical extracellular matrix or collagen-based biologic dressing. The patient presents to an outpatient wound clinic or ambulatory surgical center for application of a topical graft substitute. The clinician (wound care specialist, dermatologist, or podiatrist) evaluates the wound, debrides nonviable tissue, measures wound dimensions, and prepares the wound bed. Q4241 (Polycyte, for topical use only, per 0.5 cc) is opened and applied directly to the wound surface in measured aliquots; multiple units may be used based on wound size. The encounter includes procedural wound care supplies, dressing application, and post-application instructions. Typical sites of service are outpatient wound care clinics, physician offices, ambulatory surgical centers, and hospital outpatient departments. Common indications include nonhealing diabetic foot ulcers, venous stasis ulcers, pressure ulcers, and surgical wound dehiscence requiring a topical biologic scaffold to support healing.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to apply Q4241 is substantially greater than usual (eg, extensive debridement or complex preparation). |